Loading
Latest filing published 22 Jul 2010 for Advanced Life Sciences Holdings, Inc., €1.5M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Michael T. Flavin appears in our data through filings on Advanced Life Sciences Holdings, Inc. shares, published by SEC (Form 4). Between 18 May 2006 and 22 July 2010, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 3 purchases worth €15k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant.
A typical purchase (the median) is worth €5,988.
On 22 July 2010 came the latest disclosure, a share grant for €1.5M in Advanced Life Sciences Holdings, Inc. The most recent open-market purchase was published on 28 February 2008, 6,813 days ago. Most trades are made public on the day they happen. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations